‘WHO Informal Consultation on
Development of Guidelines on Procedures and Data Requirements for
 Changes to Approved Biotherapeutic Products including Biosimilars’
‘International Symposium on Procedures and Data Requirements for 
Manufacturing Changes to Approved Biologicals’

26-28 April, 2017          Seoul, South Korea

​About Meetings

International Symposium on Procedures and Data Requirements for

Manufacturing Changes to Approved Biologicals

Seoul, South Koea
26 April, 2017

Place: Sheraton Seoul Palace Gangnam Hotel Grand Ballroom B1F

Attendees: Experts of WHO, Representatives of each nation,

                    The Person of pharmaceutical industry, academia and research institutes            

※ English-Korean simultaneous interpretation

WHO Informal Consultation on Development of Guidelines on Procedures and Data Requirements for Changes to Approved Biotherapeutic Products including Biosimilars'

27-28 April, 2017
Seoul, South Koea

Place: Sheraton Seoul Palace Gangnam Hotel Grand Ballroom B1F

Attendees: Representative of WHO CCs at eight nations, Experts of WHO, 

                    Ministry of Food and Drug Safety

※ This meeting is a closed meeting that only invitees can participate in

Welcome Message

I have the pleasure of inviting you to attend the open symposium on 29th June 2016 in Seoul, Republic of Korea and also the 3rd CC network meeting, which will take place in Osong from 30th June to 1st July.

The increasing cross-border mobility of people, commodities and materials that characterizes globalization has raised the potential threat of emerging infectious diseases such as SARS, MERS, Ebola and Zika virus. Effective prevention and control of infectious diseases require strengthened inter-country cooperation, prompt information sharing, active exchanges of experts as well as enhanced public-private partnerships.

The open symposium aims:

a)  to bring experts from WHO, CCs, NRAs, academia and industry to share information
     on ongoing researches and product development

b) to discuss inter-governmental collaborative efforts, the roles of NRAs, partnership with
     research institutes, academic laboratories and private sectors

We would be grateful for your active participation and contribution to this open symposium by sharing current trends and experiences in research and regulation of medicinal products in your country.

Yeowon Sohn,

PhDDirector General,

National Institute of

Food and Drug Safety Evaluation

Ministry of Food and Drug Safety

Registation & Contact

If you have any request or need our assistance,

please contact us.

Tel: +82 (0)70-4268-9066

Fax: +82 (0)2 430-5745

e-mail: K.miceteam@gmail.com

(28159) 187, Osongsaengmyeong 2-ro, Yeonje-ri, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

© 2018 by Ministry of Food and Drug Safety

Secretariat for Symposium & WHO Workshop
바이오의약품 GMP 국제 심포지엄 & 워크숍 사무국